touchfocus expanding the reach of her2 in solid tumours: a spotlight on tumour-agnostic approaches
Published 3 weeks ago • 30 plays • Length 15:09Download video MP4
Download video MP3
Similar videos
-
34:21
expanding options for her2 advanced breast cancer: taking trial data to the clinic
-
5:00
pivotal data on targeting her2 in her2-expressing solid tumors
-
4:33
the her pathway and cancer
-
5:30
significance of her2 expression in solid tumors
-
51:24
her2 and her3 alterations as therapeutic targets of increasing significance in solid tumors
-
20:11
her2-positive breast cancer—reduce your risk of recurrence | access health
-
5:03
giant cell arteritis | presentation, diagnosis and treatment
-
14:08
her2 amplification and breast cancer part 1
-
0:44
what is a her2 tumor?
-
5:00
her2 testing strategies across tumor types amidst guidelines gaps
-
0:34
helping to address unmet needs in metastatic hr /her2- breast cancer
-
3:24
her2 testing and clinical decision making in gastroesophageal adenocarcinoma guideline
-
4:46
her2 mutations in cancer
-
40:56
new horizons in high-risk hr her2- ebc: risk stratification for early identification
-
3:35
understanding the her2climb trial
-
1:14
prognostic value of beta-2 adrenergic receptor levels in her2 breast cancer
-
6:58
her2climb and nala trials: r/r her2 mbc
-
34:06
the emerging role of serd's in hr breast cancer
-
2:34
her2climb: sequencing in metastatic breast cancer
-
30:57
treatment updated for her2 positive breast cancer: changing paradigms
-
2:04
shining a spotlight on cancer cells